Are GLP-1 Treatments the Future for Type 1 Diabetes?
For patients with type 1 diabetes, achieving optimal glycemic control with the current treatments can be difficult. But GLP-1s may provide the solution. In this episode, Children's of Alabama endocrinologists Dr. Giovanna Beauchamp and Dr. Ortal Resnick discuss their research on this topic and the difference GLP-1 receptor agonists could make for patients with type 1 diabetes.
More From Current Show
Thanks to medical advances, people with cystic fibrosis (CF) are living longer than they used to. But with...
Listen Now As director of Developmental Therapeutics at the University of Alabama at Birmingham and Children's of Alabama, Jamie Aye,...
Listen Now For decades, doctors have relied heavily on ultrasound scans to monitor kidney health in children with spina bifida....
Listen Now In recent years, endocrinologists at Children’s of Alabama have seen a drastic increase in the number of young...
Listen Now Children’s of Alabama nephrologist Dr. Michael Seifert and his lab are using a novel technique called spatial transcriptomics,...
Listen Now The independent risk for neurodevelopmental impairments attributed to chorioamnionitis (inflammation of the fetal membranes) in premature infants remains...
Listen Now Last year, Curtis J. Rozzelle, M.D., a pediatric neurosurgeon at the University of Alabama at Birmingham (UAB), performed...
Listen Now Testicular torsion is a serious medical emergency that requires immediate surgical intervention. If not treated promptly, the condition...
Listen Now Related Episodes
Vivir con diabetes puede ser difícil. No está solo. En este podcast, Shelli Calhoun, educadora en diabetes, habla...
Listen Now 
Living with diabetes can be hard. You are not alone. In this podcast, Shelli Calhoun, diabetes educator, discusses...
Listen Now 
Cook County Health Endocrinologist, Dr. Uzma Syed, breaks down how PCOS is diagnosed, including the role of hormone...
Listen Now Prediabetes doesn't have to lead to diabetes. In this podcast, Gretchen Johnson, dietitian at the Bryan Diabetes Center,...
Listen Now 
Dr. Richard Sterling describes how a simple calculation using routine blood tests, called the FIB‑4 index, has changed...
Listen Now 
Glucagon-like peptide 1 receptor agonists (GLP1RAs) are widely used to treat type 2 diabetes mellitus (T2DM) and obesity....
Listen Now 
A clear, practical overview of the most important diabetes signs and why early detection matters for patients and...
Listen Now 
Diabetes technology is changing the way people monitor blood sugar, take insulin and manage daily life. In this...
Listen Now 
